Literature DB >> 15857138

N-terminal fatty acylated His-dPhe-Arg-Trp-NH(2) tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes.

Aleksandar Todorovic1, Jerry Ryan Holder, Rayna M Bauzo, Joseph Walker Scott, Renny Kavanagh, Zalfa Abdel-Malek, Carrie Haskell-Luevano.   

Abstract

The melanocortin system is involved in the regulation of a diverse number of physiologically important pathways including pigmentation, feeding behavior, weight and energy homeostasis, inflammation, and sexual function. All the endogenous melanocortin agonist ligands possess the conserved His-Phe-Arg-Trp tetrapeptide sequence that is postulated to be important for melanocortin receptor molecular recognition and stimulation. Previous studies by our laboratory resulted in the discovery that increasing alkyl chain length at the N-terminal "capping" region of the His-dPhe-Arg-Trp-NH(2) tetrapeptide resulted in a 100-fold increased melanocortin receptor agonist potency. This study was undertaken to systematically evaluate the pharmacological effects of increasing N-capping alkyl chain length of the CH(3)(CH(2))(n)CO-His-dPhe-Arg-Trp-NH(2) (n = 6-16) tetrapeptide template. Twelve analogues were synthesized and pharmacologically characterized at the mouse melanocortin receptors MC1R and MC3R-MC5R and human melanocytes known to express the MC1R. These peptides demonstrated melanocortin receptor selectivity profiles different from those of previously published tetrapeptides. The most notable results of enhanced ligand potency (20- to 200-fold) and receptor selectivity were observed at the MC1R. Tetrapeptides that possessed greater than nine alkyl groups were superior to alpha-MSH in terms of the stimulation of human melanocyte tyrosinase activity. Additionally, the n-pentadecanoyl derivative had a residual effect on tyrosinase activity that existed for at least 4 days after the peptide was removed from the human melanocyte culture medium. These data demonstrate the utility, potency, and residual effect of melanocortin tetrapeptides by adding N-terminal fatty acid moieties.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857138     DOI: 10.1021/jm0490843

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Position and length of fatty acids strongly affect receptor selectivity pattern of human pancreatic polypeptide analogues.

Authors:  Veronika Mäde; Kathrin Bellmann-Sickert; Anette Kaiser; Jens Meiler; Annette G Beck-Sickinger
Journal:  ChemMedChem       Date:  2014-08-22       Impact factor: 3.466

2.  Peptide modifications differentially alter G protein-coupled receptor internalization and signaling bias.

Authors:  Veronika Mäde; Stefanie Babilon; Navjeet Jolly; Lizzy Wanka; Kathrin Bellmann-Sickert; Luis E Diaz Gimenez; Karin Mörl; Helen M Cox; Vsevolod V Gurevich; Annette G Beck-Sickinger
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-25       Impact factor: 15.336

3.  Discovery of Melanocortin Ligands via a Double Simultaneous Substitution Strategy Based on the Ac-His-dPhe-Arg-Trp-NH2 Template.

Authors:  Aleksandar Todorovic; Cody J Lensing; Jerry Ryan Holder; Joseph W Scott; Nicholas B Sorensen; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2018-06-11       Impact factor: 4.418

4.  Melanocortin antagonist tetrapeptides with minimal agonist activity at the mouse melanocortin-3 receptor.

Authors:  Skye R Doering; Aleksandar Todorovic; Carrie Haskell-Luevano
Journal:  ACS Med Chem Lett       Date:  2014-12-29       Impact factor: 4.345

5.  Discovery of Mixed Pharmacology Melanocortin-3 Agonists and Melanocortin-4 Receptor Tetrapeptide Antagonist Compounds (TACOs) Based on the Sequence Ac-Xaa1-Arg-(pI)DPhe-Xaa4-NH2.

Authors:  Skye R Doering; Katie T Freeman; Sathya M Schnell; Erica M Haslach; Marvin Dirain; Ginamarie Debevec; Phaedra Geer; Radleigh G Santos; Marc A Giulianotti; Clemencia Pinilla; Jon R Appel; Robert C Speth; Richard A Houghten; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2017-05-15       Impact factor: 7.446

6.  Third transmembrane domain of the adrenocorticotropic receptor is critical for ligand selectivity and potency.

Authors:  Yingkui Yang; Vinod Mishra; Chiquito J Crasto; Min Chen; Reed Dimmitt; Carroll M Harmon
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

7.  Molecular identification of the human melanocortin-2 receptor responsible for ligand binding and signaling.

Authors:  Min Chen; Charles J Aprahamian; Robert A Kesterson; Carroll M Harmon; Yingkui Yang
Journal:  Biochemistry       Date:  2007-09-18       Impact factor: 3.162

8.  The first preparative solution phase synthesis of melanotan II.

Authors:  Vladimir V Ryakhovsky; Georgy A Khachiyan; Nina F Kosovova; Elena F Isamiddinova; Andrey S Ivanov
Journal:  Beilstein J Org Chem       Date:  2008-10-30       Impact factor: 2.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.